Sutro Biopharma
STRO
STRO
80 hedge funds and large institutions have $189M invested in Sutro Biopharma in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 12 reducing their positions, and 2 closing their positions.
Holders
80
Holders Change
+20
Holders Change %
+33.33%
% of All Funds
1.64%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
23
Increased
35
Reduced
12
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$9.87M |
| 2 |
DCM
2
Driehaus Capital Management
Chicago,
Illinois
|
$509K |
| 3 |
O
3
OrbiMed
New York
|
$0 |
| 4 |
VM
4
VV Manager
Boston,
Massachusetts
|
$2.84M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$640K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CSS
76
Cubist Systematic Strategies
Stamford,
Connecticut
| $4K | +$4K | +534 | New |
|
|
PCM
77
Prelude Capital Management
New York
| $3K | +$750 | +100 | +33% |
|
78
Osaic Holdings
Scottsdale,
Arizona
| $2K | – | – | – |
|
|
O
79
OrbiMed
New York
| – | -$1.07M | -104,800 | Closed |
|
|
SIM
80
Spark Investment Management
New York
| – | -$148K | -14,587 | Closed |
|